Regulations.gov document
Amendments to Suitability Petition: Revised Dosage Form of Pimobendan Tablets.
Other · FDA-2018-P-1349 · posted Apr 27, 2018
Key facts
| Document ID | FDA-2018-P-1349-0005 |
|---|---|
| Title | Amendments to Suitability Petition: Revised Dosage Form of Pimobendan Tablets. |
| Document type | Other |
| Subtype | Amendment |
| Agency | FDA |
| Docket | FDA-2018-P-1349 |
| Posted | Apr 27, 2018 |
| Comment period opens | Apr 27, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: